B Cell News and Research

RSS

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.

28 Mar 2022

New, potential treatment combination for patients with aggressive head and neck cancer

The current treatment of patients diagnosed with advanced or metastatic head and neck cancer (HNC) is ineffective.

28 Mar 2022

A cluster of cells in the brainstem found to control the body's response to severe blood loss

University of Virginia School of Medicine scientists have discovered a cluster of cells in the brainstem that controls the body's response to severe blood loss, a finding which could benefit efforts to develop new treatments for traumatic injuries.

28 Mar 2022

Study shows how cells use octopus-like tentacles to move around the body

With help from the best tweezers in the world a team of researchers from the University of Copenhagen has shed new light on a fundamental mechanism in all living cells that helps them explore their surroundings and even invade tissue.

28 Mar 2022

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Researchers applied a previously developed thermostable self-amplifying ribonucleic acid vaccine to COVID-19.

28 Mar 2022

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Researchers evaluated the potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients during coughing or intense moistening with saliva.

28 Mar 2022

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

A recent study investigated the potency and functionality of T-cell and humoral responses against the SARS-CoV-2 wild-type strain and its variants.

28 Mar 2022

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Sen. Tim Scott, a rising star in the Republican Party with broad popularity in his home state of South Carolina, is getting showered with drug industry money before facing voters this fall.

28 Mar 2022

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

In this interview, we speak to Kirill Kiselyov, Ph.D, and Umamaheswar Duvvuri, M.D, Ph.D, from the University of Pittsburgh, about their latest research into hydroxychloroquine, a drug widely used to prevent and treat malaria, as a potential treatment for head and neck cancers.

28 Mar 2022

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.

27 Mar 2022

Tuberculosis infection protects mice against COVID-19

To study if prior Mtb infection affects the response to CoV2 infection, K18-hACE2 (ACE2) and C57BL/6 (B6) mice were infected with Mtb, and post thirty days, were exposed to CoV2.

27 Mar 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Biologists discover gene deletion behind abnormality in blood cancer cells

The mystery is being unraveled of why the control centers, or nuclei, of certain blood cancer cells have a distinctly odd shape.

27 Mar 2022

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that people living with HIV who are on antiretroviral treatment (ART) with protease inhibitors (PI), may have a lower risk of COVID-19 infection.

27 Mar 2022

B Cell News and Research

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

New, potential treatment combination for patients with aggressive head and neck cancer

A cluster of cells in the brainstem found to control the body's response to severe blood loss

Study shows how cells use octopus-like tentacles to move around the body

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

Tuberculosis infection protects mice against COVID-19

CDK6: a potential drug target for severe COVID-19

Biologists discover gene deletion behind abnormality in blood cancer cells

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

Researchers discover new pathway for DNA transfer in tumor microenvironment

Novel SARS-CoV-2 strains found to have low impact on CD8 T lymphocytes

New insights into SARS-CoV-2 immunity gained from natural infection

A new strategy for identifying potent miniature antibodies against emerging SARS-CoV-2 variants

Researchers show how an important inhibitor binds to the A2A receptor

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News